-- New preclinical data for PM577 in Wilson's Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1'26, with initial clinical data expected in 2027 -- -- Nominated PM647 as development candidate for Alpha-1 Antitrypsin Deficiency (AATD); on-track to file IND and/or CTA in mid-2026, with initial clinical data expected in 2027 --

SMR shares tumble 14% as soaring operating costs widen its Q3 loss, overshadowing a 1,635% revenue surge.

Frontdoor (NASDAQ: FTDR), a platform for home services that provides repair and maintenance plans for key systems and appliances, experienced a 16% drop in its stock price in just one day, now trading at $55. Although the company has a robust operational foundation and consistent profitability, investors must evaluate whether FTDR stock is genuinely built for durability — particularly when the economic cycle shifts.

USA Rare Earth (USAR) stock reached day 11 of an ongoing losing streak, accumulating a total decline of -48% during this timeframe. The company has experienced a loss of approximately $1.4 billion in value over these 11 days, with its present market capitalization around $1.8 billion.

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. (“Molina” or “the Company”) (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 2, 2025.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Unilever PLC's (LSE:ULVR) investors have had little to shout about in recent years, but Barclays reckons 2026 could finally mark a turning point. The bank believes the consumer goods giant is on course to combine steady growth with rising profitability, arguing that margins of around 20% need not be viewed as a ceiling.

Examine the evolution of Bel Fuse's (BELFB) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

American Axle & Manufacturing (AXL) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.2 per share a year ago.

Beyond analysts' top-and-bottom-line estimates for Pan American Silver (PAAS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

FirstCash (FCFS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Conduent (CNDT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.14 per share a year ago.

Evaluate the expected performance of European Wax Center (EWCZ) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

MKS (MKSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top-and-bottom-line estimates for GlobalFoundries (GFS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for HudBay Minerals (HBM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Besides Wall Street's top-and-bottom-line estimates for Cisco (CSCO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.

Enova International (ENVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Beyond analysts' top-and-bottom-line estimates for TransDigm (TDG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

Extension protects entrenched board and management rather than maximizesshareholder value; shareholders must demand an immediate vote. CHICAGO , Nov. 7, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky, long-term shareholders of Lifeway Foods, Inc. (NASDAQ: LWAY ) who together exercise voting control with respect to approximately 26% of the outstanding shares of Lifeway Foods today provided a response to the Company's extension of its existing Shareholder Rights Agreement (the "Rights Plan") as well as an update on the upcoming Lifeway Foods 2025 election.